background image

Sickle Cell Clinical Trials

Find clinical trials for sickle cell. Search for sickle cell clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

for
Sickle Cell Disease, Pain, Acupuncture,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 14 - 70+

Code: NCT06725550

Recruiting
Active & Responsive

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

for
Sickle Cell Disease
Location: Columbus OH
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 11+

Code: NCT06264700

Recruiting
Active & Responsive

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

for
Anemia, Sickle Cell, Healthy Volunteers
Location: Birmingham AL, New Haven CT, Boston MA, Philadelphia PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06481306

Phase1, Phase2, Recruiting
Active & Responsive

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Palo Alto CA, St Louis MO
Sponsor: Kamau Therapeutics

Sex: All

Age: 12 - 40

Code: NCT04819841

Phase1, Phase2, Recruiting
Active & Responsive

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Los Angeles CA, Oakland CA
Sponsor: Mark Walters, MD

Sex: All

Age: 12 - 35

Code: NCT04774536

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Low Systemic/High Local Exercise Load in Peds SCD

for
Sickle Cell Anemia in Children
Location: Jackson MS
Sponsor: University of Mississippi Medical Center

Sex: All

Age: 12 - 17

Code: NCT06387758

Recruiting
Active & Responsive

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

for
Hematologic Diseases, Anaemia, Sickle Cell
Location: Miami FL, Tamarac FL, Atlanta GA, Columbus GA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 50

Code: NCT05660265

Phase1, Recruiting
Active & Responsive

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

for
Sickle Cell Disease
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 16 - 60

Code: NCT03121001

Phase2, Recruiting
Active & Responsive

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

for
Sickle Cell Disease
Location: Birmingham AL, Phoenix AZ, Oakland CA, Augusta GA,
Sponsor: RTI International

Sex: All

Age: 18+

Code: NCT06385886

Recruiting
Active & Responsive

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

for
Sickle Cell Disease (SCD)
Location: Birmingham AL, Wilmington DE, Washington D.C. DC,
Sponsor: University of Rochester

Sex: All

Age: 3 - 20

Code: NCT06941389

Recruiting